Nearly 3.8 million people in China have already been vaccinated to prevent the potentially fatal H1N1 influenza virus.

Comparing with the 390 million people within the country who are considered at high risk of the disease, the vaccine supply is limited, Liang Wannian, deputy director of the emergency response office of the Ministry of Health, said on Nov 1.

So far, almost 52.9 million doses of the vaccine, which produced by eight domestic manufacturers, have been approved by the top drug authority. According to the ministry’s plans, 65 million people will be inoculated by the end of the year.

Now total cases and fatalities are both increasing sharply, it considered as the pandemic peaked in the Read more…

Popularity: 1% [?]

China, economy, flu, H1N1, risk, vaccine, virus

As the H1N1 flu spread all over the world, the share prices of domestic vaccine makers rose on surging order for vaccines, even the benchmark Shanghai Composite Index fell 2.83 percent.

The vaccine producer Hualan Biological rose 2.47 percent to 57.7 yuan in Shenzhen on Oct 27 while Layn Natural Ingredients rose 2.93 percent to 44.94 yuan.

As Shenzhen Neptunus Bioengineering Read more…

Popularity: 1% [?]

China, economy, flu, H1N1, market, Shanghai, vaccine